AGT and heart failure: Several studies have described changes in interactions between fibroblasts and their ECM in response to increased cardiovascular load [10], genetic hypertension [11], pacing-induced heart failure [12] or in response to biochemical factors including angiotensin II (AngII) and transforming growth factor-β (TGF-β) [10], [13].